Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Assessing glomerular filtration rate (GFR) involves collecting timed urine samples for 24 hours, requiring significant time and resources in the clinical setting. Using predictive GFR formulae to assess renal function may be a better alternative. Our goal was to determine which predictive GFR formula had the highest level of concordance with the GFR that has been measured in a resource-poor setting. This is an observational study. We selected fifty (50) individuals diagnosed with type 2 diabetes (T2DM) in Kumasi, Ghana. The sociodemographic and clinical characteristics were obtained using a structured questionnaire. Urine was obtained from each subject over 24 hours. The levels of glucose (FBG) and creatinine in patients' blood, as well as the levels of creatinine in their urine, were measured after the patients had fasted overnight. Participants had a mean age of 57.4 ± 10.7 (years), BMI of 27.8 ± 4.1 (kg/m), FBG of 9.0 ± 3.1 (mmol/L), and creatinine concentrations of 95.6 ± 29.1 (mol/L). A Krouwer plot was used to compare the measured GFR with three formulae: Chronic Kidney Disease Epidemiology (CKD-EPI), Modification of Diet in Renal Disease (MDRD), and Cockroft-Gault (CG) for GFR prediction. Among the 3 estimates, CG showed nonsignificance ( > 0.05) with the measured GFR. The primary finding was that the GFR calculated using the CG formula was not different from the GFR measured, suggesting that CG is the most appropriate alternative GFR estimate among a cross-section of T2DM patients in Ghana.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11189678PMC
http://dx.doi.org/10.1155/2024/9532236DOI Listing

Publication Analysis

Top Keywords

gfr
10
glomerular filtration
8
filtration rate
8
observational study
8
predictive gfr
8
gfr measured
8
measured gfr
8
measured
5
comparative determination
4
determination glomerular
4

Similar Publications

SIRT1 modulation and lipid profile alterations in the cellular regulation of blood lipids in renal disorders among extremely obese individuals.

Cell Mol Biol (Noisy-le-grand)

September 2025

University Sousse, Faculty of Medicine "Ibn El-Jazzar", Department of Medical Genetics, Sousse, Tunisia.

The global epidemic of overweight and obesity is closely linked to the development of chronic kidney disease (CKD), with extremely obese individuals facing a particularly high risk. This study aimed to assess the relationship between lipid profile levels, SIRT1 expression, and RNA-34a-5P in the regulation of blood lipid levels among severely obese individuals with renal diseases. Conducted over six months in three specialized hospitals, the study included 100 participants divided into two groups: 50 obese individuals with renal diseases and 50 obese controls without renal problems.

View Article and Find Full Text PDF

Introduction: Tumour-induced osteomalacia (TIO) is rare. At our referral centre, we see a substantial number of TIO. Therefore, we planned to study their profile and treatment outcomes to provide insight in management.

View Article and Find Full Text PDF

A Drug-Wide Association Study on Medications Associated With Cystatin C Estimated GFR.

Am J Kidney Dis

September 2025

Department of Population Health Sciences, Geisinger, Danville, PA; Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden.

View Article and Find Full Text PDF

Objectives: This report examines the role of age-specific trends in fertility rates in the decline in the number of births and of general fertility rates (GFRs) and total fertility rates (TFRs).

Methods: Data are from the National Center for Health Statistics' National Vital Statistics System birth data files from 1990 through 2023. To estimate the role of changes in age-specific fertility rates on total births, GFRs, and TFRs from 1990 through 2023, 1990 rates for each maternal age category were kept constant and applied to all subsequent years to produce adjusted totals and rates.

View Article and Find Full Text PDF

Aims: Renal impairment frequently coexists with heart failure (HF) and is associated with increased risk of poor clinical outcomes. This highlights the urgent need for therapies targeting both cardiac and renal dysfunction. AZD3427, a long-acting recombinant fusion protein and relaxin analogue that selectively activates the relaxin family peptide receptor 1 (RXFP1), showed trends of increased stroke volume and estimated glomerular filtration rate (eGFR) in HF patients (NCT04630067).

View Article and Find Full Text PDF